CHRISTOPHER HARPER: Open Payments
NPI 1770575854 · WARRIOR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 20 payments from 10 companies in 2025. Trend: 2023 $547 · 2024 $645 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $130 |
| ABBVIE INC. | 3 | $62 |
| Corcept Therapeutics | 2 | $45 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 2 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
Products named: Ozempic, VRAYLAR, Rybelsus, Korlym, Kerendia, XIFAXAN, ELIQUIS, JARDIANCE.
Industry payments across AL — which companies pay providers there.
